These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6108273)

  • 1. Temporal relationship of tissue somatostatin-like immunoreactivity to metabolic changes in genetically obese and diabetic mice.
    Berelowitz M; Coleman DL; Frohman LA
    Diabetes; 1980 Sep; 29(9):717-23. PubMed ID: 6108273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide content in pancreas and pituitary of obese and diabetes mutant mice: strain and sex differences.
    Timmers K; Coleman DL; Voyles NR; Powell AM; Rökaeus A; Recant L
    Metabolism; 1990 Apr; 39(4):378-83. PubMed ID: 1691431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin in the pancreas and hypothalamus of obese mice.
    Dolais-Kitabgi J; Le Marchand-Brustel Y; Freychet P
    Diabetologia; 1979 Oct; 17(4):257-61. PubMed ID: 387502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue somatostatin levels in three models of genetic obesity in rats.
    Voyles NR; Bhathena SJ; Kennedy B; Wilkins SD; Michaelis OE; Zalenski CM; Timmers KI; Recant L
    Proc Soc Exp Biol Med; 1987 May; 185(1):49-54. PubMed ID: 2883660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive neurotensin in the pancreas of genetically obese and diabetic mice. A longitudinal study.
    Berelowitz M; Frohman LA
    Diabetes; 1983 Jan; 32(1):51-4. PubMed ID: 6848397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered beta-endorphin, Met- and Leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome.
    Timmers K; Voyles NR; Zalenski C; Wilkins S; Recant L
    Diabetes; 1986 Oct; 35(10):1143-51. PubMed ID: 2944783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric analysis of obesity (ob/ob)- and diabetes (db/db)-associated hypothalamic neuronal degeneration in C57BL/KsJ mice.
    Garris DR
    Brain Res; 1989 Oct; 501(1):162-70. PubMed ID: 2804691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice.
    Orland MJ; Permutt MA
    Diabetes; 1987 Mar; 36(3):341-7. PubMed ID: 3542656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P, neurokinin A, vasoactive intestinal polypeptide and gastrin releasing peptide in the intestine and pancreas of spontaneously obese-diabetic mice.
    Bailey CJ; Flatt PR; Deacon CF; Shaw C; Conlon JM
    Regul Pept; 1986 Dec; 16(3-4):339-48. PubMed ID: 2436255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
    Garris DR; Garris BL
    Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased pancreatic somatostatin (SRIF) concentration in spontaneously diabetic mice.
    Patel YC; Orci L; Bankier A; Cameron DP
    Endocrinology; 1976 Nov; 99(5):1415-8. PubMed ID: 991829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in pancreatic somatostatin content in spontaneously diabetic mice, as determined by radioimmunoassay and immunohistochemical methods.
    Makino H; Matsushima Y; Kanatsuka A; Yamamoto M; Kumagai A; Nishimura M
    Endocrinology; 1979 Jan; 104(1):243-7. PubMed ID: 376284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique alterations of neuropeptide content in median eminence, amygdala, and dorsal vagal complex of 3- and 6-week-old diabetes mutant mice.
    Timmers KI; Palkovits M; Coleman DL
    Metabolism; 1990 Nov; 39(11):1158-66. PubMed ID: 2233277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic somatostatin contents in spontaneously diabetic KK and non-obese diabetic (NOD) mice.
    Matsushima Y; Makino H; Kanatsuka A; Osegawa M; Kumagai A; Nishimura M; Tochino Y; Makino S
    Horm Metab Res; 1982 Jun; 14(6):292-8. PubMed ID: 6126426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive neurotensin in spontaneous syndromes of obesity and diabetes in mice.
    Sheppard MC; Bailey CJ; Flatt PR; Swanston-Flatt SK; Shennan KI
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):532-6. PubMed ID: 3887830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of streptozotocin administration on somatostatin content of pancreas and hypothalamus in rats.
    Makino H; Kanatsuka A; Matsushima Y; Yamamoto M; Kumagai A
    Endocrinol Jpn; 1977 Jun; 24(3):295-9. PubMed ID: 144051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
    Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
    Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciglitazone, a new hypoglycaemic agent. 4. Effect on pancreatic islets of C57BL/6J-ob/ob and C57BL/KsJ-db/db mice.
    Diani AR; Peterson T; Sawada GA; Wyse BM; Gilchrist BJ; Hearron AE; Chang AY
    Diabetologia; 1984 Aug; 27(2):225-34. PubMed ID: 6386585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A temporal study of somatostatin secretion and its inhibitory effect in genetically diabetic mice (C57BL/KsJ-db/db).
    Basabe JC; Pivetta OH; de Bruno LF; Cresto JC; Aparicio NJ
    Endocrinology; 1983 Dec; 113(6):1927-34. PubMed ID: 6139272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.